Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering - Drug Trials For Money - Paid Clinical Trials

A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Conditions:   Gastrointestinal Epithelial Cancer;   Gastrointestinal Neoplasms;   Cancer of Gastrointestinal Tract;   Cancer, Gastrointestinal;   Gastrointestinal Cancer;   Colo-rectal Cancer;   Pancreatic Cancer;   Gall Bladder Cancer;   Colon Cancer;   Esophageal Cancer;   Stomach Cancer
Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Tumor-Infiltrating Lymphocytes (TIL);   Drug: Aldesleukin
Sponsors:   Intima Bioscience, Inc.;   Masonic Cancer Center, University of Minnesota
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2020 / by / in
Comments